ID   CMT-Star
AC   CVCL_B7H9
DR   GEO; GSM3153065
DR   GEO; GSM3153066
DR   GEO; GSM3153069
DR   GEO; GSM3153070
DR   GEO; GSM3153071
DR   GEO; GSM3153072
DR   GEO; GSM3153073
DR   GEO; GSM3153074
DR   Wikidata; Q112929389
RX   DOI=10.1080/09712119.2022.2032719;
CC   Doubling time: 24.4 +- 0.028 hours (DOI=10.1080/09712119.2022.2032719).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_B7H8 ! CMT-Stylo
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
RX   DOI=10.1080/09712119.2022.2032719;
RA   Sahabi K., Selvarajah G.T., Mokrish A., Rasedee A., Cheah Y.K.;
RT   "Development and molecular characterization of doxorubicin-resistant
RT   canine mammary gland tumour cells.";
RL   J. Appl. Anim. Res. 50:125-145(2022).
//